Liu R, Yin D, Wang D, Li C, Guo J, Liang X
Institute of Materia Medica, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100050.
Yao Xue Xue Bao. 1998 Dec;33(12):910-8.
In order to develop new generation of taxol-like anticancer agents with fewer side effects, improved activity, superior pharmacological properties and broad antitumor spectrum, along with structure-activity relationship study, a series of new taxol derivatives are to be synthesized starting from sinenxan A--a biosynthetic taxane. Eight new 14 beta-side chain taxol derivatives with 4-OH and 4-Ac were synthesized in 5 and 6 steps from semisynthetic taxoid intermediate 7, respectively. These included taxol derivatives modified at C-2 position with benzoate, m-Cl benzoate, valerate and phenylacetate. All target compounds together with two other 14 beta-side chain taxol derivatives were tested in a microtubule assembly assay, and in an in vitro cytotoxicity assay (KB, A2780, HCT-8 cell line). All compounds had no effect in the microtubule assembly assay at 10 mumol.L-1. Most of them showed marginal activity in the in vitro cytotoxicity. The structure-activity relationship was different from taxol derivatives. 2-Aliphatic ester displayed similar activity to 2-aromatic ester, which indicated that the aromatic group at C-2 position was not important for cytotoxicity. Comparing among themselves, 4-OH derivatives possessed stronger activity than 4-Ac.
为了开发新一代副作用更少、活性更高、药理性质更优且抗肿瘤谱更广的紫杉醇类抗癌药物,并进行构效关系研究,将从生物合成紫杉烷西农内酯A出发合成一系列新的紫杉醇衍生物。分别以半合成紫杉烷中间体7为原料,经5步和6步反应合成了8种带有4-OH和4-Ac的新型14β-侧链紫杉醇衍生物。这些衍生物包括在C-2位用苯甲酸酯、间氯苯甲酸酯、戊酸酯和苯乙酸酯修饰的紫杉醇衍生物。所有目标化合物以及另外两种14β-侧链紫杉醇衍生物在微管组装试验和体外细胞毒性试验(KB、A2780、HCT-8细胞系)中进行了测试。所有化合物在10 μmol·L-1时对微管组装试验均无影响。它们中的大多数在体外细胞毒性试验中表现出微弱活性。其构效关系与紫杉醇衍生物不同。2-脂肪族酯显示出与2-芳香族酯相似的活性,这表明C-2位的芳香基团对细胞毒性并不重要。相互比较时,4-OH衍生物比4-Ac衍生物具有更强的活性。